https://imedsciences.com/ editor_ijims@hotmail.com
ISSN: 2394-4137 (E) 2394-6318 (P)

IJIMS.2017.123

Type of Article: Original Research

Volume 5; Issue 1: 2018

Page No.: 565-569

DOI: 10.16965/ijims.2017.123

 

ANALYSIS OF MODE OF DELIVERY WITH VARIOUS INDUCTION TECHNIQUES IN TERTIARY CARE HOSPITAL AT RAYALASEMA REGION

Anita Ramesh Annaldasula.

Associate professor, obstetrics & Gynecology, Shanthiram Medical College, Nandyal, Kurnool, Andhra Pradesh, India.

Corresponding author: Dr. Anita Ramesh Annaldasula, Associate professor, obstetrics & Gynecology, Shanthiram Medical College, Nandyal, Kurnool, Andhra Pradesh, India. E-Mail: anitasreekanth123@gmail.com

ABSTRACT:

Induction of labour (IOL) needs to be considered when the risk–benefit analysis indicates that delivering the baby is a safer option for the baby, the mother, or both, rather than continuing the pregnancy, and when there are no clear indications for caesarean section and no contraindications for vaginal delivery. In the span of one year time we observed 200 deliveries outcome of term pregnancies subjected to various methods of induction of labour was to evaluate the outcome of pregnancy at term by elective induction of labour in order to reduce the cesarean section rate in Rayalasema region at Santhiram medical college and hospital. The results were modified Bhishop’s score were mean ± SD 6.35 ± 2.26. In that Amniotomy (normal vaginal delivery 5% and ceasarian 10%), Cerviprime (normal vaginal delivery 5.5% and ceasarian 17.5%), Foleys (normal vaginal delivery 2 and ceasarian 12.5%), Misoprostol (normal vaginal delivery 2.5% and ceasarian 12.5%), Oxytocin (normal vaginal delivery 2.5% and ceasarian 15%), Stripping (normal vaginal delivery 2.5% and ceasarian 12.5%). We also measured the Cardiac Tocograph after the induction in that Amniotomy (normal vaginal delivery 5% and ceasarian 10%), Cerviprime (normal vaginal delivery 5.5% and ceasarian 17.5%), Foleys (normal vaginal delivery 2 and ceasarian 12.5%), Misoprostol (normal vaginal delivery 2.5% and ceasarian 12.5%), Oxytocin (normal vaginal delivery 2.5% and ceasarian 15%), and Stripping (normal vaginal delivery 2.5% and ceasarian 12.5%), fetal outcome 5% of fetal were admitted in the ICU with various complications. The Cerviprime can be considered as safe, efficacious, cheap and mother and fetus friendly for the induction of labour.

Key words:  Amniotomy, Cerviprime, Foleys, Misoprostol, Oxytocin, and Stripping.

REFERENCES

  1. WHO recommendations for induction of labor. World Health Organization, 2011.
  2. Mozurkewich E, Chilimigras J, Koepke E, Keeton K, King VJ. Indications for induction of labour: a best evidence review. British Journal of Obstetrics and Gynaecology. 2009;116(5):626-36.
  3. National Institute for Health and Clinical Excellence. Induction of Labour: NICE Clinical Guideline 70, 2008.
  4. WHO recommendations for induction of labour 2011 Geneva: World Health Organization; 2011.
  5. Osaheni Lucky Lawani, Azubuike Kanario Onyebuchi, Chukwuemeka Anthony Iyoke, Chikezie Nwachukwu Okafo, Leonard Ogbonna Ajah. Obstetric Outcome and Significance of Labour Induction in a Health Resource Poor Setting. Obstetrics and Gynecology International. 2014;5.
  6. G. Bako, J. Y. Obed, and I. Sanusi. Methods of induction of labour at the University of Maiduguri Teaching Hospital, Maiduguri: a 4-year review. Nigerian Journal of Medicine. 2008;17(2):139–42.
  7. Bukola, N. Idi, M. M’Mimunya, W. M. Jean-Jose, M. Kidza, N. Isilda et al., Unmet need for induction of labor in Africa: secondary analysis fromthe 2004–2005WHO GlobalMaternal and Perinatal Health Survey (A cross-sectional survey). BMC Public Health. 2012;12:722.
  8. L. Tenore. Methods for cervical ripening and induction of labor. American Family Physician. 2003:67(10):2123–8.
  9. A. Ekele, D. C. Nnadi, M. A. Gana, C. E. Shehu, Y. Ahmed, and E. I. Nwobodo. Misoprostol use for cervical ripening and induction of labour in a Nigerian teaching hospital. Nigerian journal of clinical practice. 2007;10(3):234–7.
  10. A.Abdul,U.N. Ibrahim, M.D. Yusuf, and H.Musa. Efficacy and safety of misoprostol in induction of labour in a Nigerian Tertiary Hospital. West African Journal of Medicine. 2007;26(3):213–6.
  11. Witter and L. Devoe. Update on successful induction of labor. Advanced Studies in Medicine, 2005:5(9);888-98.
  12. Houghton Mifflin Company, The American Heritage Dictionary, 2006.
  13. Beischer NA, Mackay EV, Colditz PB. Obstetrics and the Newborn, An Illustrated Textbook 1997,3:449.
  14. Uldbjerg N, Ekman G, Malmstrom A. Ripening of the human uterine cervix related to changes in collagen, glycosaminoglycans and collagenolytic activity. Am J Obstet Gynecol.1983;147:662-6.
  15. Von Maillot K, Stunhlsatz HW, Mohanaradhakrishnan V. Changes in glycosominoglycan distribution in the human uterine cervix during pregnancy and labour. Am J Obstet Gynecol. 1979;135:503-6.
  16. Ulmstein, Wingerup L, Anderson. Comparison of Prostaglandin E2 gel and intravenous oxytocin for induction of labour. Obstet Gynecol.1979;54:581-4.
Download Full Text TOC